Novartis (NOVN:SW) (NVS) PT Lowered to CHF105 at Berenberg
Berenberg analyst Kerry Holford lowered the price target on Novartis (NOVN:SW) (NYSE: NVS) to CHF105.00 (from CHF120.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)